
The UAB at Saló de l'Ensenyament and Saló Futura
The UAB will be showcasing its academic programmes for the 2016-2017 academic year at the Saló de l'Ensenyament from 9 to 13 March and Saló Futura on 11 and 12 March.
The UAB will be showcasing its academic programmes for the 2016-2017 academic year at the Saló de l'Ensenyament from 9 to 13 March and Saló Futura on 11 and 12 March.
The Faculty of Law, in collaboration with the Community Involvement Unit, has organized a new activity that will allow you to find out more about the Síndic de Greuges de Catalunya. This activity will take place from 30 March to 20 April and can be acknowledged with 2 ECTS.
Researchers in Austria and at the UAB succeed for the first time in entangling three photons in a new asymmetric pattern. Their research, with applications in quantum cryptography, has been published in Nature Photonics.
They create a promising platform of gene therapy projects with the addition of two new therapies for Sanfilippo B (EGT-201) and Hunter syndromes (EGT-301), designated as orphan drug by the EMA and the FDA.
A study by ICTA-UAB funded by the European Research Council (ERC) shows that in indigenous societies individuals with greater local environmental knowledge catch more game and enjoy better health.
The UAB is taking part in the QS World Grad School Tour, to showcase its academic programmes in education fairs around the world. From February to May it will be in São Paulo, Rio de Janeiro, Istanbul, London, Paris, Milan and New Delhi.
After performing at the CCCB, the MACBA, MUSAC and La Pedrera, the artist Cris Blanco will present the performance Science-Fiction at the UAB Theatre, in which the artist interprets scientific theories from an artistic point of view. The performance will take place at the UAB theatre on Wednesday 2 March at 5.00 pm.
Zipf's law, a mathematical relationship that predicts word frequency, is closely adhered to by most of the texts if extremely rare words are excluded from the analysis.
Researchers from the INc have identified the biochemical and molecular alteration that causes resistance to radiotherapy and chemotherapy in glioblastoma.